252 related articles for article (PubMed ID: 8823346)
1. Antipsychotic medications in children and adolescents.
Findling RL; Grcevich SJ; Lopez I; Schulz SC
J Clin Psychiatry; 1996; 57 Suppl 9():19-23. PubMed ID: 8823346
[TBL] [Abstract][Full Text] [Related]
2. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
3. The use of antipsychotic medication in child and adolescent psychiatric treatment in Denmark. A cross-sectional survey.
Deurell M; Weischer M; Pagsberg AK; Labianca J
Nord J Psychiatry; 2008; 62(6):472-80. PubMed ID: 18841508
[TBL] [Abstract][Full Text] [Related]
4. Use of antipsychotics in children and adolescents.
Findling RL; Steiner H; Weller EB
J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
[TBL] [Abstract][Full Text] [Related]
5. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
6. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
[TBL] [Abstract][Full Text] [Related]
7. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
Aman MG; Gharabawi GM;
J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
[TBL] [Abstract][Full Text] [Related]
8. Diagnoses and antipsychotic treatment among youths in a public mental health system.
Patel NC; Crismon ML; Shafer A
Ann Pharmacother; 2006 Feb; 40(2):205-11. PubMed ID: 16434563
[TBL] [Abstract][Full Text] [Related]
9. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
Curran S; Turner D; Musa S; Wattis J
Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
[TBL] [Abstract][Full Text] [Related]
10. Psychotropic medication in adolescents: a review.
Rifkin A; Wortman R; Reardon G; Siris SG
J Clin Psychiatry; 1986 Aug; 47(8):400-8. PubMed ID: 2874127
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
[TBL] [Abstract][Full Text] [Related]
12. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
Woods SW; Gueorguieva RV; Baker CB; Makuch RW
Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
[TBL] [Abstract][Full Text] [Related]
13. Use of atypical antipsychotics in the treatment of autistic disorder.
Stachnik JM; Nunn-Thompson C
Ann Pharmacother; 2007 Apr; 41(4):626-34. PubMed ID: 17389666
[TBL] [Abstract][Full Text] [Related]
14. Use of atypical antipsychotic medications in adolescent psychiatric inpatients: a comparison with inpatients who did not receive antipsychotic medications during their stay.
Pogge DL; Young K; Insalaco B; Harvey PD
Int J Clin Pract; 2007 Jun; 61(6):896-902. PubMed ID: 17504351
[TBL] [Abstract][Full Text] [Related]
15. [Risperidone use in child and adolescent psychiatric patients].
Chevreuil C; Reymann JM; Frémaux T; Polard E; Séveno T; Bentué-Ferrer D
Therapie; 2008; 63(5):359-75. PubMed ID: 19154706
[TBL] [Abstract][Full Text] [Related]
16. Phenomenology and epidemiology of childhood psychiatric disorders that may necessitate treatment with atypical antipsychotics.
DelBello M; Grcevich S
J Clin Psychiatry; 2004; 65 Suppl 6():12-9. PubMed ID: 15104522
[TBL] [Abstract][Full Text] [Related]
17. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
Baghdadli A; Gonnier V; Aussilloux C
Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
[TBL] [Abstract][Full Text] [Related]
18. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.
Olfson M; Blanco C; Liu L; Moreno C; Laje G
Arch Gen Psychiatry; 2006 Jun; 63(6):679-85. PubMed ID: 16754841
[TBL] [Abstract][Full Text] [Related]
19. New users of antipsychotic medications among children enrolled in TennCare.
Cooper WO; Hickson GB; Fuchs C; Arbogast PG; Ray WA
Arch Pediatr Adolesc Med; 2004 Aug; 158(8):753-9. PubMed ID: 15289247
[TBL] [Abstract][Full Text] [Related]
20. Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychoses.
McConville BJ; Sorter MT
J Clin Psychiatry; 2004; 65 Suppl 6():20-9. PubMed ID: 15104523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]